M. Herzog
Research Subjects
Research Interests
M. Herzog has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
A. Besarab
1 shared publication- Anatoliy A. Sokol1 shared publication
I. Skorokhod
1 shared publication- Liudmyla Dolinchuk
Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland
1 shared publication - Marcus Frohme
Technical University of Applied Sciences Wildau image/svg+xml
1 shared publication - N. Shchotkina1 shared publication
Latest Publications
- Open Access
- 30 June 2023
- Published by Institute of Cell Therapy in Cell and Organ Transplantology
- Vol. 11 (1)
Features of technological regulation for cardiac bioimplants
Patients with congenital heart defects and cardiovascular diseases are required new approaches to surgical intervention. The use of biological cardiac implants, which are made from the extracellular matrix, is a promising trend in modern regenerative medicine. These bioimplants can completely replace defective tissue or organs, and when manufactured with strict protocols and quality control measures, can be safe and effective for therapeutic applications. The process of manufacturing bioimplants involves various risks that need to be assessed and mitigated with ongoing monitoring and evaluation necessary to ensure the highest standards of quality. Overall, this study was successfully evaluated the requirements for introducing a new medical device into practice and created a technical file that meets all necessary documentation for certification.
- 30 June 2023
- Published by Institute of Cell Therapy in Cell and Organ Transplantology
- Vol. 11 (1)
Open AccessFeatures of technological regulation for cardiac bioimplants
Patients with congenital heart defects and cardiovascular diseases are required new approaches to surgical intervention. The use of biological cardiac implants, which are made from the extracellular matrix, is a promising trend in modern regenerative medicine. These bioimplants can completely replace defective tissue or organs, and when manufactured with strict protocols and quality control measures, can be safe and effective for therapeutic applications. The process of manufacturing bioimplants involves various risks that need to be assessed and mitigated with ongoing monitoring and evaluation necessary to ensure the highest standards of quality. Overall, this study was successfully evaluated the requirements for introducing a new medical device into practice and created a technical file that meets all necessary documentation for certification.